Navigation Links
Use of opioids for pain in ERs on the rise, but racial differences in use still exist
Date:1/1/2008

In the last 15 years, use of opioid medications to treat patients with pain-related emergency department visits has improved although white patients were more likely to receive opioids than patients of a different race/ethnicity, according to a study in the January 2 issue of JAMA.

In the 1990s, national attention focused on increasing awareness of the problem of inadequately treated pain. Also, racial and ethnic minority groups appeared to be at higher risk of receiving inadequate treatment for pain in the emergency department, according to background information in the article. National quality improvement initiatives were implemented in the late 1990s, followed by substantial increases in opioid (narcotic agents used for pain relief) prescribing in the United States, but it is unknown whether opioid prescribing for treatment of pain in the emergency department has increased and whether differences in opioid prescribing by race/ethnicity have decreased.

Mark J. Pletcher, M.D., M.P.H., of the University of California, San Francisco, and colleagues examined whether opioid prescribing is increasing in U.S. emergency departments for patients presenting with pain and whether non-Hispanic white patients are more likely to receive an opioid than other racial/ethnic groups. Pain-related visits to U.S. emergency departments were identified using reason-for-visit and physician diagnosis codes from thirteen years (1993-2005) of The National Hospital Ambulatory Medical Care Survey.

During the survey years, pain-related visits accounted for 156,729 of 374,891 (42 percent) emergency department visits. An opioid analgesic was prescribed at 29 percent of pain-related visits. This proportion increased during the study period, from 23 percent in 1993 to 37 percent in 2005. Despite this time trend, the researchers found no evidence that the difference in opioid prescribing by race/ethnicity diminished over time. Averaged over the 13 survey years, opi
'/>"/>

Contact: Wallace Ravven
415-476-2557
JAMA and Archives Journals
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Cancer Patients Hold Fast to Belief That Opioids Mean Death
2. With Obesity, Diabetes, and Cardiovascular Disease on the Rise, Physicians Need More Comprehensive Guidelines
3. Mailman School of Public Health study examines link between racial discrimination and substance use
4. Can racial health disparities be effectively reduced?
5. Racial and ethnic differences in colorectal cancer emphasize importance of screening
6. No racial differences seen in outcomes after liver transplantation
7. Genetic differences point to ethnic and racial disparities in colorectal cancer risk
8. Racial and ethnic differences in the biology of breast cancer tumors
9. Survival differences by race most apparent in advanced stages of breast cancer
10. Gene Studies of Male-Female Differences Often Flawed
11. Major differences revealed in how local authorities in the UK support disabled people

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)... variation believed to affect circadian rhythm,...-- New research suggests that an internal body clo... development of bipolar disorder in children. ,...genetic makeup of 152 children with bipolar disord...d swings, and 140 children without the disorder. T...
(Date:11/27/2009)...AS, Nov. 27 Considered ... only 25 years ago, solid organ transplantation is...the extraordinary men and women who gathered at th...rs came together from medical centers around the w...egional Transplant Institute (BRTI), one of the pi...
(Date:11/27/2009)... XenaCare Holdings has announced that it ...ndation, one of the largest nonprofit organization...h education. , Delray Bea...ngs, Inc. (OTCBB: XCHO), a company specializing in... healthcare products, has announced today that is ...
(Date:11/27/2009)... Multi-purpose bilingual coloring books d...e by the business community to educate - inform pa...from Safety issues to Dinosuars to ABC,S and a hos...t Louis, MO (PRWEB) November 27, 2009 -- Today&rsq...toys to keep them busy any hour of the day, but on...
(Date:11/26/2009)... years, the number of Americans living with diabet...n in 2009 to 44.1 million in 2034. Over the same p...sing from $113 billion to $336 billion, even with ...ers based at the University of Chicago report in t...er of those with diabetes covered by Medicare will...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...N FRANCISCO, Jan. 12 Within health care, dermatol...g quality care to their,patients. , The Dermat...logy,professionals the most up-to-date evidence-ba...nual conference slated for March,4-7 at the Hilton...
... , HOUSTON, Jan. 12 Cyberonics, Inc. (Nasdaq: ...., joined Cyberonics as Vice President, Research a.... Morris will lead all of the company,s developmen...olina, where he has served as Director, Program Ma...
... Miss., Jan. 12 A partnership between Command Spa... one of the country,s leading providers of nursing...f job-specific Spanish language instruction for nu.... Two new courses are available online to nurses n...
..., WASHINGTON, Jan. 12 Sharing Miracles, a 30-minu...e compelling and inspirational stories of real pat... at www.SharingMiracles.com . Sharing Miracles al...nominee and former star of Family Ties Meredith Ba...
...TON, Mass., Jan. 12 Alseres Pharmaceuticals, Inc...ived notice from the NASDAQ Stock Market ("NASDAQ"...he market value of its listed securities has been ... does not comply with NASDAQ Marketplace Rule 4310...
...RK and SAN FRANCISCO, Jan. 12 WeissComm Group, th...t independent communications agency focused exclus...ommunications, an agency focused on helping compan...y companies to cultivate unique brands that resona...
Other Medicine News:Health News:Hop the Trolley for DNA's 27th Annual Conference 2Health News:Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development 2Health News:Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development 3Health News:Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development 4Health News:Nurses: Command Spanish Online's Occupational Spanish Language Course Accepted for Credit by the American Nurses Credentialing Center (ANCC) 2Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 2Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 3Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 4Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 5Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 6Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 2Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 3Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 4Health News:WeissComm Group Acquires Strategic Branding Firm ODA and Enters Alliance With Patient-Focused Health Advocacy Strategies to Diversify Business and Expand Offerings 2Health News:WeissComm Group Acquires Strategic Branding Firm ODA and Enters Alliance With Patient-Focused Health Advocacy Strategies to Diversify Business and Expand Offerings 3
(Date:11/27/2009)...llnesses caused by subtypes A and B influenza viru...USNewswire/ -- The U.S. Food and Drug Administrati... and older to prevent disease caused by influenza ....newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ,,...agnostics in Siena, Italy, was approved using the ...
(Date:11/27/2009)...wire/ -- ACUO TECHNOLOGIES, developers of high-per...igration tools and services, is pleased to announc...ce has approved a patent application for an "Asset...Acuo Technologies is pleased to add the U.S. paten...neral, the granted patent application broadly prot...
(Date:11/26/2009)...ov. 26 The 2009 Frost & Sulliv...eneric Pharmaceutical Market is presented to Cipla.../www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,...ng criteria were used to benchmark Cipla Medpro,s ...gy and implementation, degree of innovation in bus...
Breaking Medicine Technology:FDA Approves Agriflu Seasonal Influenza Vaccine 2Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 1Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 2Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 3Powerhouses in the cell dismantled 14501 1Powerhouses in the cell dismantled 14501 2The future of electricity may be found in environmentally friendly thermoelectric cells 14499 1
... Calif., Oct. 29 Vermillion, Inc.,(OTC Bulletin B...h Quest,Diagnostics to extend the Strategic Allian...2009. This extension will enable the companies to ...tion of two tests, OVA1(TM) and,VASCLIR(TM)., The...ian tumors that,are at high risk of being malignan...
... trial data for Perforomist(TM) Solution presented... Oct. 29 Data from a Phase IIIb,clinical trial de...e),Inhalation Solution nebulized treatment provide...satisfaction compared to albuterol/ipratropium by,...ted today in Philadelphia,at CHEST 2008, the annua...
Other Medicine Technology:Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 2Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 3Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 4Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 2Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 3Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 4Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 5Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 6
Laser Contact Lens CGRL
Laser 3 mirror Contact Lens 630 L
...apture and management system that acquires extreme...ICG Angiography images. It interfaces with most cu...om any ophthalmic device with video, digital or TW... Retinal Images from non-mydriatic fundus cameras....
...that replaces the old technology, the automated pr...y bringing virtually unlimited charts to the patie...actitioners finger tips. The STIMULi supports man...sion tests and fixation devices in a simple remote...
Medicine Products: